179 related articles for article (PubMed ID: 1551260)
1. Thrombolytic therapy for myocardial infarction: a perspective of clinical trialists. The GUSTO Investigators.
Califf RM; Topol EJ
Clin Cardiol; 1992 Mar; 15(3):143-4. PubMed ID: 1551260
[No Abstract] [Full Text] [Related]
2. GUSTO (Global Utilization of Streptokinase and Tissue plasminogen activator in Occluded arteries): logic wins at last.
Bassand JP
Eur Heart J; 1994 Jan; 15(1):2-4. PubMed ID: 8174579
[No Abstract] [Full Text] [Related]
3. The GUSTO trial: is the open-artery hypothesis proven?
Stringer KA; Lindenfeld J
Ann Pharmacother; 1994 Jan; 28(1):97-8. PubMed ID: 8123971
[No Abstract] [Full Text] [Related]
4. Comparisons of characteristics and outcomes among women and men with acute myocardial infarction treated with thrombolytic therapy. GUSTO-I investigators.
Weaver WD; White HD; Wilcox RG; Aylward PE; Morris D; Guerci A; Ohman EM; Barbash GI; Betriu A; Sadowski Z; Topol EJ; Califf RM
JAMA; 1996 Mar; 275(10):777-82. PubMed ID: 8598594
[TBL] [Abstract][Full Text] [Related]
5. Clinical trials and decisions for thrombolytic therapy in patients with acute myocardial infarction.
Conti CR
Clin Cardiol; 1990 May; 13(5):307-8. PubMed ID: 2112073
[No Abstract] [Full Text] [Related]
6. Thrombolytic therapy of myocardial infarction--it's time for science, not marketing: the perspective of a practicing cardiologist.
Vogel JH
Clin Cardiol; 1991 Jul; 14(7):548. PubMed ID: 1810292
[No Abstract] [Full Text] [Related]
7. The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction.
GUSTO Angiographic Investigators
N Engl J Med; 1993 Nov; 329(22):1615-22. PubMed ID: 8232430
[TBL] [Abstract][Full Text] [Related]
8. Thrombolytic therapy for myocardial infarction.
Guerci AD
Md Med J; 1990 Apr; 39(4):377-81. PubMed ID: 2110282
[TBL] [Abstract][Full Text] [Related]
9. "Rescue" thrombolysis with intracoronary tissue plasminogen activator for failed intravenous thrombolysis with streptokinase for acute myocardial infarction.
White HD; Cross DB; Williams BF; Norris RM; Woo KS; Hamer AW; Elliott JM; Ormiston JA
Am J Cardiol; 1995 Jan; 75(2):172-4. PubMed ID: 7810496
[No Abstract] [Full Text] [Related]
10. Which thrombolytic agent should one choose?
Topol EJ
Prog Cardiovasc Dis; 1991; 34(3):165-78. PubMed ID: 1947122
[No Abstract] [Full Text] [Related]
11. Issues raised by GUSTO.
White H
Aust N Z J Med; 1993 Dec; 23(6):739-41. PubMed ID: 8141715
[TBL] [Abstract][Full Text] [Related]
12. Breaking the thrombolytic gridlock: insights from the GUSTO trial.
Topol EJ
Cleve Clin J Med; 1993; 60(6):445-7. PubMed ID: 8287504
[No Abstract] [Full Text] [Related]
13. More on the GUSTO Trial.
Lomaestro BM
Ann Intern Med; 1994 Nov; 121(10):818-9. PubMed ID: 7944069
[No Abstract] [Full Text] [Related]
14. GUSTO, TIMI and the case for rapid reperfusion.
Cannon CP; Braunwald E
Acta Cardiol; 1994; 49(1):1-8. PubMed ID: 8184639
[No Abstract] [Full Text] [Related]
15. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction.
GUSTO investigators
N Engl J Med; 1993 Sep; 329(10):673-82. PubMed ID: 8204123
[TBL] [Abstract][Full Text] [Related]
16. Thrombolytic therapy for acute myocardial infarction: GUSTO criticized.
Friedman HS
N Engl J Med; 1994 Feb; 330(7):504; author reply 505-6. PubMed ID: 8289861
[No Abstract] [Full Text] [Related]
17. Global utilization of streptokinase and tPA for occluded arteries (GUSTO) ECG-monitoring substudy. Study design and technical considerations.
Krucoff MW; Green CL; Langer A; Klootwijk LJ; Trollinger KM; Sawchak ST; Wilderman NM; Veldkamp RF; Pope JE; Simoons ML
J Electrocardiol; 1993; 26 Suppl():249-55. PubMed ID: 8189133
[No Abstract] [Full Text] [Related]
18. Influence of the global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries (GUSTO-1) trial on the use of thrombolytics in Germany. ALKK Study Group. Arbeitsgemeinschaft der Leitenden Kardiologischen Krankenhausärtze.
Zahn R; Rustige J; Koch A; Schiele R; Burczyk U; Schuster S; Harmjanz D; Boppert D; Gottwik M; Neuhaus KL; Senges J
Am J Cardiol; 1997 Nov; 80(10):1339-43. PubMed ID: 9388110
[TBL] [Abstract][Full Text] [Related]
19. Intravenous administration of a thrombolytic agent is the only realistic therapeutic approach in evolving myocardial infarction.
Verstraete M
Eur Heart J; 1985 Jul; 6(7):586-93. PubMed ID: 3930247
[No Abstract] [Full Text] [Related]
20. tPA fast by GUSTO.
Horton R
Lancet; 1993 May; 341(8854):1188. PubMed ID: 8098084
[No Abstract] [Full Text] [Related]
[Next] [New Search]
